| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.38 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |